ASPG and DAD1 are potential placental-derived biomarkers for ASD-like symptom severity levels in male/female offspring.
Placenta
; 155: 78-87, 2024 Sep 26.
Article
en En
| MEDLINE
| ID: mdl-39154487
ABSTRACT
INTRODUCTION:
An early evaluating system for autism spectrum disorder (ASD) severity is crucial. Questionnaire survey is challenging for accurately assessing the severity levels for ASD in children.METHODS:
Offspring with ASD-like phenotypes were induced by treating pregnant mice with Poly (IC) at GD12.5 and the placentae corresponding to the offspring were obtained by caesarean. The autism severity composite score (ASCS) for offspring was calculated through behavioral tests. HE staining and immunohistochemistry were used to observe the morphology of placenta. Candidate biomarkers were identified by weighted protein co-expression network analysis (WPCNA) combined with machine learning and further validated by ELISA. Sperman's was used to analyze the correlation between biomarkers and metabolome.RESULTS:
The placental weight and mean vascular area of male offspring with ASD-like phenotypes were significantly decreased compared with typical mice. According to the WPCNA, four modules were identified and significantly correlated with ASCS of offspring. Two biomarkers (ASPG and DAD1) with high correlation with ASCS in offspring were identified.DISCUSSION:
VEGF pathway may contribute to sexual dimorphism in placental morphology within mice with ASD-like phenotypes in term. The placental ASPG and DAD1 levels could reflect ASD-like symptom severity levels in male/female mice offspring.Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Placenta
/
Asparaginasa
/
Proteínas Reguladoras de la Apoptosis
/
Trastorno del Espectro Autista
/
Proteínas de la Membrana
Límite:
Animals
/
Pregnancy
Idioma:
En
Revista:
Placenta
Año:
2024
Tipo del documento:
Article
País de afiliación:
China
Pais de publicación:
Países Bajos